Thomson Medical Group prices 5-year $175m senior bond

This is the second bond to be issued under its multicurrency debt programme.

Thomson Medical Group has priced its 5-year SGD senior bond on Monday worth $175m, an announcement revealed.

This is the firm’s second bond issuance pursuant to its $500m Multicurrency Debt Issuance Programme launched in 2019.

The bond offering was 2.4 times oversubscribed. Thomson Medical Group will utilise the proceeds to refinance its existing debts and extend its debt maturity profile.

DBS Bank, Maybank Kim Eng Securities and Standard Chartered Bank (Singapore) are appointed as joint bookrunners of the bond offering.

Reaching the people who run Asia's businesses is harder than it used to be.

Inboxes are crowded. Attention is short. The executives you most want to reach — the founders, CFOs, and operators who actually move budgets — are the hardest to find through the usual channels. If you're building a company, a category, or a reputation, you already know this.

We've spent twenty years building the room they read. Singapore Business Review is where senior decision makers in Singapore and across Southeast Asia come for business coverage they can't get elsewhere — in print, online, and in person at the summits and roundtables we host across seven markets.

If you have something these readers should know about — a point of view worth publishing, a product worth their attention, an event worth their time — we'd like to hear what you're trying to do.

Book a meeting

| Or download the media kit (PDF)

240,000 senior readers quarterly in print Top 1,700 Singapore companies reached

7 markets across Southeast Asia